John Wiley & Sons, Inc. (NYSE:WLY – Get Free Report) announced a quarterly dividend on Thursday, December 12th,NASDAQ Dividends reports. Shareholders of record on Thursday, December 26th will be given a dividend of 0.3525 per share on Thursday, January 9th. This represents a $1.41 dividend on an annualized basis and a yield of 3.08%. The ex-dividend date is Thursday, December 26th. This is a boost from John Wiley & Sons’s previous quarterly dividend of $0.35.
John Wiley & Sons has increased its dividend payment by an average of 0.7% per year over the last three years and has increased its dividend every year for the last 26 years. John Wiley & Sons has a dividend payout ratio of 38.1% indicating that its dividend is sufficiently covered by earnings.
John Wiley & Sons Price Performance
Shares of WLY stock opened at $45.84 on Friday. John Wiley & Sons has a fifty-two week low of $30.45 and a fifty-two week high of $53.96. The company has a debt-to-equity ratio of 1.26, a quick ratio of 0.61 and a current ratio of 0.66. The firm has a market capitalization of $2.48 billion, a price-to-earnings ratio of -50.37 and a beta of 0.85. The stock’s 50-day simple moving average is $50.07 and its 200-day simple moving average is $46.17.
Insider Activity at John Wiley & Sons
In related news, EVP Danielle Mcmahan sold 2,318 shares of the company’s stock in a transaction that occurred on Tuesday, October 8th. The stock was sold at an average price of $49.41, for a total value of $114,532.38. Following the sale, the executive vice president now owns 8,978 shares in the company, valued at $443,602.98. This represents a 20.52 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.62% of the stock is owned by insiders.
John Wiley & Sons Company Profile
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
Read More
- Five stocks we like better than John Wiley & Sons
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Special Dividend?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.